Advertisement
Advertisement

Contact Person

Dr. Elinor Switzer

Managing Editor

Phone: +49 (0)711 - 2 29 87 63
Fax: +49 (0)711 - 2 29 87 65
send an Email


Archive

Vitamin K: The coagulation vitamin that became omnipotent

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
DOI: http://dx.doi.org/10.1160/TH07-04-0266
Issue: 2007: 98/1 (July) pp. 1-257
Pages: 120-125

Vitamin K: The coagulation vitamin that became omnipotent

Ellen C. M. Cranenburg, Leon J. Schurgers, Cees Vermeer
VitaK & Cardiovascular Research Institute CARIM, University of Maastricht, Maastricht, The Netherlands

Keywords

diagnostics, oral anticoagulants, vitamin K, matrix Gla protein, osteocalcin

Summary

Vitamin K, discovered in the 1930s, functions as cofactor for the posttranslational carboxylation of glutamate residues. Gammacarboxy glutamic acid (Gla)-residues were first identified in prothrombin and coagulation factors in the 1970s; subsequently, extra-hepatic Gla proteins were described,including osteocalcin and matrix Gla protein (MGP).Impairment of the function of osteocalcin and MGP due to incomplete carboxylation results in an increased risk for developing osteoporosis and vascular calcification, respectively, and is an unexpected side effect of treatment with oral anticoagulants. It is conceivable that other side effects, possible involving growth-arrest-specific gene 6 (Gas6) protein will be identified in forthcoming years. In healthy individuals, substantial fractions of osteocalcin and MGP circulate as incompletely carboxylated species, indicating that the majority of these individuals is subclinically vitamin K-deficient. Potential new application areas for vitamin K are therefore its use in dietary supplements and functional foods for healthy individuals to prevent bone and vascular disease, as well as for patients on oral anticoagulant treatment to offer them protection against coumarin- induced side effects and to reduce diet-induced fluctuations in their INR values.

You may also be interested in...

1.

E. C. M. Cranenburg (1), R. Koos (2), L. J. Schurgers (1), E. J. Magdeleyns (1), T. H. M. Schoonbrood (3), R. B. Landewé (3), V. M. Brandenburg (2, 4), O. Bekers (5), C. Vermeer (1)

Thromb Haemost 2010 104 4: 811-822

http://dx.doi.org/10.1160/TH09-11-0786

2.
Ellen C. M. Cranenburg1,*; Vincent M. Brandenburg2,*; Cees Vermeer1; Melanie Stenger2; Georg Mühlenbruch3; Andreas H. Mahnken3; Ulrich Gladziwa4; Markus Ketteler2; Leon J. Schurgers1

Thromb Haemost 2009 101 2: 359-366

http://dx.doi.org/10.1160/TH08-04-0241

3.

Martin J. Shearer1, Paul Newman2

Thromb Haemost 2008 100 4: 530-547

http://dx.doi.org/10.1160/TH08-03-0147